Seres Therapeutics outlines global Phase II SER-155 trial with 248-patient enrollment amid partnership talks

‘Where’s the money going?’: why Brazilian towns awash with royalties from oil are still among the poorest | Inequality and development

• August 6, 2025
• Roubens Andy King